top of page
Search

New Publication: Relief and Prevention of Post-Traumatic Headache Using Intranasal Delivery of Lidocaine for Youth (RAPPIDLY)

3 days ago
1 min read

Our team is excited to announce that we have published a new paper in Neurotrauma Reports. This paper explored the use of intranasal Lidocaine to help relieve and prevent headaches post-concussion. What our team found was that Lidocaine, which is a local anesthetic medication, helped reduce post-concussion headaches in a sample of participants post-concussion. Participants noted that the medication was well tolerated, with no serious adverse effects.


Why is this important? New treatment methods, like this, can be feasibly delivered in a clinic by trained professionals and may have a positive impact on patient outcomes. Continuing to explore new avenues of treatment is a priority of the TRANSCENDENT Concussion Research Program.



 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.

The TRANSCENDENT Concussion Research Program is an Integrated Discovery Program carried out in partnership with the Ontario Brain Institute, 360 Concussion Care and the CHEO Research Institute. 

Please contact us with any questions or inquiries.

Ontario Brain Institute Logo – Proud Partner and Funder Supporting Advancements in Brain Health and Concussion Research
360 Concussion Care Logo – Clinical Partner Specializing in Comprehensive Concussion Assessment, Treatment, and Rehabilitatio
TRANSCENDENT Concussion Research Program
  • X
  • LinkedIn
  • Instagram
  • Youtube
  • Facebook
Screen Shot 2026-02-09 at 9.36.14 AM.png

Copyright 2025 TRANSCENDENT Concussion Research Program, All Rights Reserved. 

bottom of page